Bupivacaine provides rapid, effective periprostatic anaesthesia for transrectal prostate biopsy
Article first published online: 27 MAY 2004
Volume 93, Issue 9, pages 1216–1217, June 2004
How to Cite
Rabets, J.C., Jones, J.S., Patel, A.R. and Zippe, C.D. (2004), Bupivacaine provides rapid, effective periprostatic anaesthesia for transrectal prostate biopsy. BJU International, 93: 1216–1217. doi: 10.1111/j.1464-410X.2004.04843.x
- Issue published online: 27 MAY 2004
- Article first published online: 27 MAY 2004
- Accepted for publication 6 February 2004
- prostate biopsy;
- local anaesthesia;
To examine the effectiveness of the longer acting agent bupivacaine in providing periprostatic anaesthesia during transrectal ultrasonography (TRUS)-guided biopsy, as the periprostatic injection of lidocaine has been shown to significantly alleviate the pain of this procedure.
PATIENTS AND METHODS
Seventy-five patients were randomized to receive a periprostatic injection with either bupivacaine, a lidocaine/bupivacaine (1/1) combination, or no local anaesthesia. Immediately before biopsy 5 mL of the anaesthetic was injected under TRUS guidance into the periprostatic nerves bilaterally. After taking a 10-core biopsy the patients were given a visual analogue scale (VAS; 0–10) to assess their pain during the procedure.
The mean VAS scores were 2.04 in the bupivacaine group and 4.46 in the control (no local anaesthetic) group (P < 0.001).
Bupivicaine provides significant, immediate periprostatic anaesthesia for TRUS biopsy.